NDC codes

FDA NDC Directory
Product NDC (as listed)75907-054Labeler and product segments. Claims need a package NDC.
Product NDC at billing width75907-0054Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
75907-054-607590700546060 CAPSULE in 1 BOTTLE, PLASTIC (75907-054-60)Marketed from May 28, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Dofetilide
Generic name (nonproprietary)
dofetilide
Active ingredients
Dofetilide — .5 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Dr. Reddy's Labratories Inc.NDC labeler code 75907
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 207058
Marketing start
Marketing end
Identifiers
Product ID 75907-054_cfb67967-e633-9056-6d99-c42ec7905f2eSPL ID cfb67967-e633-9056-6d99-c42ec7905f2eSPL set ID 28fe0cac-62fd-997d-8065-561aaf1541c4RxCUI 310003, 310004, 310005UNII R4Z9X1N2NDUPC 0375907056604
Pharmacologic class
Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475907005460 followed by a unit qualifier and the quantity

Package 75907-0054-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence) Dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. Because dofetilide capsules can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. In general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. Recurrence is expected…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 75907-054

What is NDC 75907-054?
75907-054 is the product NDC for Dofetilide, Dofetilide .5 mg/1 capsule, listed with the FDA by Dr. Reddy's Labratories Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Dofetilide.
What is the active ingredient?
Dofetilide.
Who is the labeler?
Dr. Reddy's Labratories Inc., NDC labeler code 75907. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dofetilide?
31 other product NDCs are listed under this name. See all Dofetilide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dofetilide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
DofetilideDofetilide .125 mg/1CapsuleOralREMEDYREPACK INC.70518-473870518-4738-0070518-4738-01
DofetilideDofetilide .25 mg/1CapsuleOralREMEDYREPACK INC.70518-461770518-4617-00
DofetilideDofetilide .25 mg/1CapsuleOralEXELAN PHARMACEUTICALS, INC.76282-75676282-0756-60
DofetilideDofetilide .125 mg/1CapsuleOralEXELAN PHARMACEUTICALS, INC.76282-75576282-0755-60
DofetilideDofetilide .5 mg/1CapsuleOralEXELAN PHARMACEUTICALS, INC.76282-75776282-0757-60
DofetilideDofetilide .125 mg/1CapsuleOralMajor Pharmaceuticals0904-752200904-7522-08
DofetilideDofetilide .25 mg/1CapsuleOralMajor Pharmaceuticals0904-752300904-7523-08
DofetilideDofetilide .5 mg/1CapsuleOralMajor Pharmaceuticals0904-752400904-7524-08
DofetilideDofetilide .25 mg/1CapsuleOralDr. Reddy's Labratories Inc.75907-05575907-0055-60
DofetilideDofetilide .125 mg/1CapsuleOralDr. Reddy's Labratories Inc.75907-05675907-0056-60

All 32 Dofetilide NDCs

Other NDCs under ANDA 207058

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207058
ProductStrengthForm · routeLabelerProduct NDC
DofetilideDofetilide .25 mg/1CapsuleOralDr. Reddy's Labratories Inc.75907-055
DofetilideDofetilide .125 mg/1CapsuleOralDr. Reddy's Labratories Inc.75907-056
DofetilideDofetilide .125 mg/1CapsuleOralMajor Pharmaceuticals0904-7522
DofetilideDofetilide .25 mg/1CapsuleOralMajor Pharmaceuticals0904-7523
DofetilideDofetilide .5 mg/1CapsuleOralMajor Pharmaceuticals0904-7524

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in